Zafiris J. Daskalakis, MD, PhD

JCP
rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies
Commentary

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.
Cory R. Weissman, Richard A. Bermudes, Jeffrey Voigt, et al
JCP
Meta-Analysis

January 18, 2022

Repetitive magnetic transcranial stimulation (rTMS) has been established as an efficacious treatment for MDD. This meta-analysis looked at its effects on suicidal ideation in depressed patients across the lifespan.
Shobha Mehta, Gerasimos Konstantinou, Cory R. Weissman, et al
JCP
Original Research

October 19, 2021

Magnetic seizure therapy (MST) has shown promise as an alternative to electroconvulsive therapy for acute treatment-resistant depression (TRD). This study examines the efficacy of MST as a continuation treatment...
Victor M. Tang, Daniel M. Blumberger, Alanah Throop, et al
JCP
Original Research

April 17, 2018

Read a study on the effects of rTMS on suicidal ideation in patients with treatment-resistant major depression (TRD).
Cory R. Weissman, Daniel M. Blumberger, Patrick E. Brown, et al
JCP
Original Research

April 26, 2017

ECT is effective in patients with schizophrenia who do not respond to clozapine or cannot take it due to adverse effects. This study, conducted in a large sample using...
Tyler S. Kaster, Zafiris J. Daskalakis, Daniel M. Blumberger
JCP
Original Research

November 1, 2002

Sitra Tauscher-Wisniewski, Shitij Kapur, Johannes Tauscher, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe